health 𧬠Huntington's Disease market set for big growth
The global Huntington's Disease market is predicted to grow robustly at a 14% CAGR until 2036. This growth is driven by the upcoming introduction of disease-modifying gene and RNA-based therapies across the 7MM. In 2025, the market was valued at around USD 320 million, with 44,000 cases noted in the United States. New treatments like SKY-0515 and Votoplam are showing promising results in ongoing clinical trials. These breakthroughs aim to shift treatment from purely symptomatic care to disease modification.